ArticleGeneral thoracic and cardiovascular surgery cases2026
Life-saving staged management of a secondary aortoesophageal fistula after arch replacement: a case report.
Article in General thoracic and cardiovascular surgery cases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAortoesophageal fistula (AEF) after thoracic aortic repair is a rare and devastating complication with an extremely high mortality (33-100%). Although emergency thoracic endovascular aortic repair (TEVAR) can provide immediate hemostasis, it does not address the underlying infection and therefore is insufficient for long-term survival. A staged multidisciplinary strategy may improve outcomes in selected patients: initial hemodynamic stabilization, early source eradication (esophagectomy), and delayed reconstruction. CASE PRESENTATION: A 78-year-old woman, who had undergone total arch replacement 6 years prior, presented with sudden haematemesis. Endoscopy and CT confirmed secondary AEF. Emergency TEVAR successfully stabilized bleeding. Two days later, the patient underwent thoracoscopic oesophagectomy, cervical oesophagostomy, jejunostomy, and omental flap coverage. Parvimonas micra was isolated intraoperatively, and targeted antimicrobial therapy was continued for eight weeks. After achieving infection control and nutritional optimization, presternal ileocolonic reconstruction was performed on postoperative day 69. She was discharged home 94 days after the initial intervention and remains well, free of recurrence, at 7 months post-TEVAR.
conclusionThis case highlights the critical role of a well-executed staged strategy in contributing to favorable clinical outcomes from secondary AEF. Immediate TEVAR served effectively as a life-saving bridge. Crucially, the early multidisciplinary coordination allowed for the prompt removal of the oesophageal source within 48 h, an intervention essential to prevent uncontrolled mediastinal sepsis. This sequence-haemostasis, early source control, and delayed extra-anatomical reconstruction-may provide a reasonable strategy for survival in selected high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.